Triple Flag Precious Metals reports $106.7 million Q3 revenue
Triple Flag Precious Metals (NYSE:TPFM) reported third-quarter 2026 revenue of $106.7 million, supported by quarterly metal sales of 25,030 gold equivalent ounces (GEOs).
Every story in this section, newest first — page 34 of 373.
Triple Flag Precious Metals (NYSE:TPFM) reported third-quarter 2026 revenue of $106.7 million, supported by quarterly metal sales of 25,030 gold equivalent ounces (GEOs).
Intel (NASDAQ:INTC) shares gained in premarket trading after Bloomberg News reported that the chipmaker remains involved in Elon Musk’s planned Terafab semiconductor manufacturing project.
Fortuna Mining (NYSE:FSM) reported third-quarter 2026 production of 69,665 gold equivalent ounces across its three operating mines, compared with 72,217 ounces in the second quarter and 72,462 ounces in the third quarter of 2025.
Brent Crude futures rose to $101.39 a barrel as the market weighed US Gulf storm threats.
Grupo Aeroportuario del Pacífico (NYSE:PAC) recorded a 7.3% year-over-year decline in September 2026 terminal passenger traffic.
Figure Technology Solutions (NASDAQ:FIGR) reported preliminary third-quarter consumer loan marketplace volume of $5,119 million.
Ballard Power Systems (NASDAQ:BLDP) secured a 4.8 MW fuel cell order from Siemens Mobility for 12 passenger trains in Romania.
Nurix Therapeutics (NASDAQ:NRIX) enrolled the first patient in its Phase 1b/2 clinical study combining bexobrutideg with venetoclax for the treatment of chronic lymphocytic leukemia.
VAALCO Energy (NYSE:EGY) brought its final offshore Gabon development well into production to add 1,140 net barrels daily.
Oculis (NASDAQ:OCS) will present its investigational dry eye treatment, Licaminlimab, at the Eyecelerator @ AAO 2026 conference on October 8.
CRH (NYSE:CRH) announced that it has signed an agreement to acquire NCC Industry’s operations in Denmark and Finland from NCC AB.
Esperion Therapeutics (NASDAQ:ESPR) entered into a settlement agreement with Renata and an affiliate resolving patent litigation concerning proposed generic versions of NEXLETOL and NEXLIZET in the United States.
CoreWeave (NASDAQ:CRWV) announced plans to expand its AI cloud platform into India through a collaboration with AdaniConneX, with the companies planning to develop 240 megawatts (MW) of data center capacity in Navi Mumbai.
Pershing Square (NYSE:PS) stock surged 7.49 percent to $58.98 following an updated coverage note from Jefferies.
Village Super Market (NASDAQ:VLGEA) reported fourth-quarter net income of $13.6 million alongside a 1.6 percent increase in total retail sales to $609.6 million.
Quantum BioPharma (NASDAQ:QNTM) signed a study agreement with Thermo Fisher Scientific (NYSE:TMO) to implement its Phase 2 trial.
VinFast (NASDAQ:VFS) signed an initial partnership with NexMove to supply electric buses to United States customers by 2028.
Bluejay Diagnostics (NASDAQ:BJDX) released baseline data for its SYMON-II clinical validation study featuring 777 evaluable sepsis patients.
Telix Pharmaceuticals (NASDAQ:TLX) commenced U.S. distribution of its brain cancer imaging drug Pixclara with its first patient doses.
Surf Air Mobility (NYSE:SRFM) signed a definitive commercial agreement with Clipper Aviation to deploy its OperatorOS flight operations software.
Institutional digital asset exchange Bullish (NYSE:BLSH) reported total trading volume of $48.6 billion for September 2026.
Miami International Holdings (NYSE:MIAX) released its September 2026 trading volume metrics, highlighting sustained year-to-date expansion across its options execution venues.
Skydance (NYSE:SKYD), formerly Paramount Skydance, finalized its acquisition of Warner Bros. Discovery (NASDAQ:WBD) following the satisfaction of all regulatory approvals and closing conditions.
Tradeweb Markets (NASDAQ:TW) reported total trading volume of $81.6 trillion for September 2026 alongside an average daily volume of $3.7 trillion.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy